83 International, expanded-access programme of everolimus in patients with metastatic renal cell carcinoma who progressed after prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: Sub-analysis of European patients

✍ Scribed by S. Bracarda; S. Rottey; A. Bahl; C. Eichelberg; B. Mellado; L. Mangel; J. Mardiak; I. Bouzaklas; A. Panneerselvam; V. Grünwald

• Book ID: 119624019
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 35 KB
• Volume: 11
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/s1569-9056(12)60082-7